Firebrick Pharma Limited (ASX:FRE)
Australia · Delayed Price · Currency is AUD 0.0290
+0.0010 (3.57%)
Oct 9, 2026, 11:29 AM AEST
Firebrick Pharma Market Cap
Firebrick Pharma has a market cap or net worth of 8.33 million as of October 8, 2026. It is the 44,380th most valuable company in the world and the 1,404th biggest in Australia. Its market cap has decreased by 49.60% in one year.
Market Cap
8.33M
Enterprise Value
7.01M
Revenue
135.62K
Global Rank
Country Rank
#1,404 Australia
PE Ratio
n/a
ChartMarket Cap Chart
Since January 28, 2022, Firebrick Pharma's market cap has decreased from 89.49M to 8.33M, a decrease of -90.69%. That is a compound annual growth rate of -39.67%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 9, 2026 | 8.33M | -37.23% |
| Dec 30, 2025 | 13.27M | 1.87% |
| Dec 31, 2024 | 13.03M | 46.33% |
| Dec 29, 2023 | 8.90M | -77.12% |
| Dec 29, 2022 | 38.92M | -56.51% |
| Jan 28, 2022 | 89.49M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| CSL Limited | 87.16B |
| Sigma Healthcare | 30.37B |
| Pro Medicus | 16.71B |
| Ramsay Health Care | 12.56B |
| Adheris Health | 9.57M |
| Careteq | 9.53M |
| Invex Therapeutics | 8.27M |
| Percheron Therapeutics | 7.29M |